POS1156 THE ANTIRHEUMATIC DRUG IGURATIMOD MITIGATES DISUSE OSTEOPOROSIS IN MICE BY INHIBITING SCLERO...
POS1156 THE ANTIRHEUMATIC DRUG IGURATIMOD MITIGATES DISUSE OSTEOPOROSIS IN MICE BY INHIBITING SCLEROSTIN AND RANKL PRODUCTION THROUGH THE ERK/EGR1/TNF-Α PATHWAY IN OSTEOCYTES
About this item
Full title
Author / Creator
Miura, T. , Ebina, K. , Etani, Y. , Noguchi, T. , Hirao, M. , Takami, K. , Goshima, A. , Kurihara, T. , Fukuda, Y. , Ochiai, N. , Kanamoto, T. , Nakata, K. and Okada, S.
Publisher
Kidlington: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Limited
Subjects
More information
Scope and Contents
Contents
Background:Disuse osteoporosis is a prevalent complication among patients with rheumatoid arthritis (RA). The treatment of disuse osteoporosis has been reported to diminish the efficacy of conventional osteoporosis drugs. Therefore, alternative therapeutic approaches distinct from conventional osteoporosis treatments are necessary. A meta-analysis...
Alternative Titles
Full title
POS1156 THE ANTIRHEUMATIC DRUG IGURATIMOD MITIGATES DISUSE OSTEOPOROSIS IN MICE BY INHIBITING SCLEROSTIN AND RANKL PRODUCTION THROUGH THE ERK/EGR1/TNF-Α PATHWAY IN OSTEOCYTES
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3065951411
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3065951411
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2024-eular.1024
